Gerald E. Quirk - 11 Oct 2022 Form 3 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Signature
/s/ Todd Rosenthal, as attorney-in-fact
Issuer symbol
SYRS
Transactions as of
11 Oct 2022
Net transactions value
$0
Form type
3
Filing time
13 Oct 2022, 16:15:50 UTC
Next filing
14 Sep 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SYRS Common Stock 8,700 11 Oct 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SYRS Stock Option (right to buy) 11 Oct 2022 Common Stock 13,998 $133.00 Direct F1
holding SYRS Stock Option (right to buy) 11 Oct 2022 Common Stock 3,999 $109.00 Direct F1
holding SYRS Stock Option (right to buy) 11 Oct 2022 Common Stock 7,499 $100.90 Direct F1
holding SYRS Stock Option (right to buy) 11 Oct 2022 Common Stock 6,718 $67.10 Direct F1
holding SYRS Stock Option (right to buy) 11 Oct 2022 Common Stock 6,069 $75.40 Direct F1
holding SYRS Stock Option (right to buy) 11 Oct 2022 Common Stock 3,719 $114.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested.

Remarks:

Exhibit 24 - Power of Attorney